Study Stopped
Trial was rewritten and will no longer focus on the link between smoking and depression.
Pennsylvania Adolescent Intervention Research Study (PAIRStudy)
TRIAD Project: Pennsylvania Adolescent Intervention Research Study (PAIRStudy; Project 3a)
1 other identifier
interventional
240
1 country
3
Brief Summary
Through the TRIAD Project: Pennsylvania Adolescent Intervention Research Study (PAIRStudy; Project 3a) we aim to test the efficacy of a brief treatment aimed at treating depression and family conflict among a population of adolescents with depression, and thereby reducing the future chance of these adolescents initiating smoking. We will examine Attachment-Based Family Therapy (ABFT) for the treatment of depression in comparison with Enhanced Usual Care for Depression (EUCd). Reduction of depression will be measured by a clinically significant reduction of score on the Hamilton Rating Scale for Depression. Second, we will examine how reduction of family conflict mediates the effect of ABFT on depression. The third aim will be an exploratory look at the potential prevention of the onset of smoking. Specifically, we will examine if reduction of depression and/or reductions in family conflict regardless of treatment type reduces the initiation of smoking or reduces smoking behavior at 52 weeks. These aims will be accomplished by randomizing 240 adolescents to one of two treatment conditions: a) Attachment-Based Family Therapy or b) Enhanced Usual Care for Depression. Patients randomized to the ABFT condition will receive 6-12 weeks of family therapy. Patients enrolled in the EUCd condition will be referred for outpatient psychological services at an agency that fits their geographic and financial needs. Research staff will help patients navigate the referral process. All participating therapists will have carried out the full, manualized treatment with 2-3 pilot cases prior to treating any randomized cases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2 depression
Started Dec 2006
Shorter than P25 for phase_2 depression
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2006
CompletedFirst Posted
Study publicly available on registry
May 24, 2006
CompletedStudy Start
First participant enrolled
December 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedAugust 20, 2007
August 1, 2007
May 22, 2006
August 16, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in depression as measured by the Hamilton Depression Rating Scale-17.
Secondary Outcomes (1)
Smoking initiation or cessation at week 52, as measured by the Timeline Follow-Back.
Interventions
Eligibility Criteria
You may qualify if:
- to 17 years of age
- HAM-D score of \> 14
- Meet diagnostic criteria for either Major Depressive Disorder, Dysthymia, or Depression NOS
- Have a parent or guardian willing to participate
You may not qualify if:
- Currently Suicidal
- History of mental retardation or borderline intellectual functioning
- Current psychosis
- Primary caregiver unwilling to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pennsylvania Department of Healthlead
- Children's Hospital of Philadelphiacollaborator
- University of Pittsburghcollaborator
- Lehigh Valley Hospitalcollaborator
Study Sites (3)
Lehigh Valley Hospital
Allentown, Pennsylvania, 18104, United States
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19146, United States
The Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guy S Diamond, Ph.D.
The Children's Hospital of Philadelphia/ University of Pennsylvania
- PRINCIPAL INVESTIGATOR
Donald Schwarz, M.D.
Children's Hospital of Philadelphia
- STUDY DIRECTOR
Suzanne A Levy, Ph.D.
Children's Hospital of Philadelphia
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
May 22, 2006
First Posted
May 24, 2006
Study Start
December 1, 2006
Study Completion
May 1, 2007
Last Updated
August 20, 2007
Record last verified: 2007-08